Laminaphin Tablets (Terbinafine Hydrochloride)

Adult dosage

For adults, administer 125 mg of terbinafine once, twice daily, or 250 mg once daily. The duration of treatment varies according to the condition: 1) Dermatophyte infections Athlete's foot (interdigital type, plantar type/moccasin type): 2 to 6 weeks Tinea corporis: 2 to 4 weeks Tinea cruris (jock itch): 2 to 4 weeks 2) Onychomycosis Generally administered for 6 weeks to 3 months. For infections on nails or relatively small toes, or in younger patients, treatment duration may be shortened to less than 3 months. For nail infections, a treatment duration of around 3 months is usually sufficient, but in some patients, it may take 6 months or longer. In patients with slow nail growth, the treatment duration may be extended.

Children's dosage

Administer to children over 2 years old. 1) For children weighing less than 20 kg (under 5 years old): 62.5 mg once, administered once a day. Due to limited experience, consider the benefits and risks of treatment before administering.

This medication is not recommended for patients with chronic liver disease or active liver disease. Regular liver function tests should be conducted before and during treatment, and the medication should be discontinued immediately if symptoms of liver dysfunction appear. Patients suspected of having liver dysfunction or damage should consult a doctor promptly, as serious side effects such as liver failure can occur rarely. Do not take this medication if there is a hypersensitivity reaction, blood disorders, severe renal failure, in infants under 2 years old, lactating women, or patients with certain genetic lactose intolerance. Patients with decreased kidney function, the elderly, children weighing less than 20 kg, and those with skin conditions should use this medication cautiously, and if serious skin reactions occur, the medication should be discontinued immediately. This medication can cause various side effects; if symptoms such as nausea, vomiting, fatigue, rash, myalgia, headache, visual impairment, etc., occur, notify healthcare professionals immediately. Be cautious while driving or operating machinery, as dizziness and other symptoms may occur. If taken with other medications, interactions may occur, so all medications being taken should be reported to a doctor or pharmacist, and dosage adjustments may be necessary. Women who are pregnant or may become pregnant should be cautious when using this medication, and breastfeeding women should discontinue breastfeeding during treatment. In case of overdose, symptoms such as headache, nausea, abdominal pain, dizziness may occur, and if these symptoms appear, visit the hospital immediately. Keep this medication out of reach of children and store it at room temperature away from direct sunlight.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, paleness, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in mouth/eye mucous membranes, severe skin abnormal reactions, shortness of breath or difficulty in breathing, asthma attacks, respiratory abnormalities with cough and fever, jaundice, yellowing of skin or eyes, extreme lethargy, liver abnormalities, sudden and severe headaches, flash-like headaches

Mild side effects

• Nausea
• loss of appetite
• fatigue
• vomiting
• upper abdominal pain
• dark urine
• soft stools
• rash
• skin itching
• fever

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle